Featured Articles

1. 5 Best Practices For Getting Started With ePRO 9/16/2024

   Unlock the potential of electronic Patient Reported Outcomes (ePRO) in your clinical research by implementing these essential best practices for success.

2. Understanding Phase 4 Trials: A Critical Component Of Post-Marketing Insight 9/16/2024

   Uncover how Phase 4 trials play an essential role in gathering additional real-world data on the treatment’s performance over a longer period of time and in more diverse patient populations.

3. Fulfilling MDR Requirements For A Groundbreaking Microsurgery Robot 8/19/2024

   Uncover how Castor accelerated MMI's mission to advance robotic technology and expand the boundaries of open surgery, creating new opportunities for surgeons to restore the quality of life for patients with complex conditions.

4. An Expert's View On Choosing And Developing An eCOA Strategy 8/19/2024

   Dive into the insights from our recent LinkedIn Live discussion where Derk Arts, CEO of Castor, and Joe Dustin, VP at Biofourmis explored how a standardized approach to eCOA could transform clinical trials and streamline data collection.

5. Do We Still Need Patients In Tomorrow's Trials? 8/19/2024

   Delve into how advanced technologies reshape drug development and patient care, and the crucial balance needed between innovation and ethical responsibility to achieve better trial outcomes.

6. DTx Company Leverages Real-World Evidence Platform In Registry Study 8/19/2024

   Discover how Castor’s eClinical system enabled a groundbreaking study in behavioral disorder treatment to collect Real-World Evidence (RWE) to support product research and claims.

7. Navigating The Evolving Regulatory And Data Landscape 8/19/2024

   Explore how real-world evidence is reshaping clinical research and learn why precision and innovation are key to staying ahead in this evolving landscape.

8. 5 Key Takeaways From The FDA's Real-World Evidence Guidance 8/19/2024

   With our advanced technology and expertise, sponsors can confidently conduct RWE studies that are efficient and aligned with the FDA’s data-driven vision for healthcare.

9. How Optina Diagnostics Used EDC In Earlier Disease Detection 5/15/2024

   Understand how Optina Diagnostics streamlined operations and achieved significant milestones by leveraging Castor's tools in its effort to revolutionize the diagnostic process for Alzheimer’s.

10. Measuring The True Patient Experience 5/15/2024

    Utilizing the insights covered in this article can inform the design and implementation of cancer trials, ultimately contributing to improved patient care and treatment outcomes.